Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

Tim Dekker(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), Cornelis J.�H. van de Velde(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Vincent T.H.B.M. Smit(Leiden University Medical Center), Judith R. Kroep(Leiden University Medical Center), JP Julien(Centre Henri Becquerel), Gabi W. van Pelt
Breast Cancer Research and Treatment
May 24, 2013
Cited by 155


Related Papers